Latest news and events
Latest News from the Partnership
2020.09.09 | Research news
The Nordic EMBL Partnership and COVID-19
Across the Nordic EMBL Partnership, a wide range of projects are underway to help tackle the ongoing COVID-19 pandemic. The Partnership is home to a high number of highly talented young group leaders, recruited according to the EMBL model, who are well equipped to help contribute towards research into diseases and societal emergencies like…
2020.09.03 | Research news
ERC starting grants for two Nordic EMBL Partnership group leaders
The Nordic EMBL Partnership wishes to congratulate Dr. Andrea Ganna, group leader at FIMM, and Dr. Jonas Barandun, group leader at MIMS, on receiving an ERC Starting Grant.
2020.08.28 | Research news
First mosquito cell atlas published in Science
Professor Oliver Billker, Director of MIMS, is a senior author on the paper, 'Mosquito cellular immunity at single-cell resolution'; findings that will help researchers to further understand how mosquitoes fight malaria and other infections.
2020.08.24 | People
Welcome to: Dominik Fischer, Science Manager
Dr. Dominik Fischer joined MIMS in June 2020 as Science Manager. Here, he explains more about his role and what the Nordic EMBL Partnership annual meeting will look as it takes place online for the first time in September 2020.
2020.08.05 | People
Meet Katja Kivinen, Research Director of the FIMM Technology Centre & HiLIFE Deputy Director for Research Infrastructures
Katja Kivinen leads the FIMM (Institute for Molecular Medicine Finland Technology Centre), which provides state-of-the-art biomedical research services to national and international research groups. Dr Kivinen is also HiLIFE Deputy Director for Research Infrastructures. In this interview, Dr. Kivinen speaks about her role as Research Director and…
2020.07.11 | People
Welcome to: Dr. Sebastian Waszak
Dr. Waszak joined NCMM in March 2020 as head of the Computational Oncology group.Dr Waszak completed his postdoc at EMBL Heidelberg in the group of Jan Korbel. In this article, he describes his research into precision medicine for young people with cancer, the role that rare genetic disorders can play when it comes to cancer treatment, and what…
2020.07.02 | Research news
Paula Lindner: Joint PhD student, DANDRITE and NCMM
Paula Lindner defended her PhD on 9 June 2020. Her PhD was a joint project between NCMM, Faculty of Medicine, University of Oslo, and DANDRITE (the Danish Research Institute of Translational Neuroscience, Aarhus), Aarhus University.
2020.06.26 | Research news
High profile review publication on antibiotic resistance from the Hauryliuk and Atkinson labs, MIMS
In this review, published in the influential journal Nature Reviews Microbiology, Umeå researchers Vasili Hauryliuk (also affiliated with Tartu University, Estonia) and Gemma C. Atkinson, together with their collaborators Daniel N. Wilson (University of Hamburg, Germany) and Alex J. O’Neill (University of Leeds, UK) discuss an important and…
2020.06.03 | People
Welcome to Hanna M. Ollila
Dr. Hanna M. Ollila is a FIMM-EMBL Group Leader at the Institute for Molecular Medicine Finland (FIMM), based at the University of Helsinki. Hanna specializes in the genetics of sleep and brain autoimmunity. In this interview, Hanna sheds some light on her field of research and elaborates on future plans for her newly established research group.
2020.05.22 | Research news
Researcher profile: Camila Esguerra
Dr Camila Esguerra joined NCMM in 2014. Her research involves using zebrafish as a model to study brain function in health and disease. In this profile article, Camila discusses her research career so far, the benefits of using zebrafish in translational research, and her visions and plans for the future.
Upcoming Partnership Events
News on publications
2019.11.08 | Publication, Knowledge exchange
Targeted Gene Modification in Animal Pathogenic Chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.
2019.10.30 | Publication, Knowledge exchange, People
New article from Irep Gözen: how did the first cell division event take place?
NCMM group leader Irep Gözen recently published a perspectives article in ACS Nano, where she presents a new hypothesis for how cells were first able to divide on the early earth.
2019.10.14 | Publication, Research news, Knowledge exchange, People
Yonehara group at DANDRITE have identified a new circuit mechanism in mammalian retinal motion computation
Latest research from the group led by Keisuke Yonehara at DANDRITE has recently been published in peer-reviewed scientific journal “Current Biology”. The study is about the space-time wiring between a type of motion-sensitive cells that project to the brain for gaze stabilization and local excitatory cells in the mouse retina.
2019.09.11 | Publication, Research news
Research from the Sekulic Group provides new molecular insights into the structure and function of the centromer
New work from the group led by Nikolina Sekulic at NCMM has been published in EMBO Reports. The study sheds light on the structure of nucleosomes contained within the centromere; findings that will help to improve our understanding of the important molecular events that drive cell mitosis.
2019.07.28 | Publication
Miniaturized version of ribosome found in microsporidia
A research team lead by MIMS/SciLifeLab research group leader Jonas Barandun uses cryo-electron microscopy to provide near atomic details of the smallest known eukaryotic cytoplasmic protein synthesis machine, the microsporidian ribosome.
2019.06.13 | Publication
DrugComb, a one-stop solution to all your cancer drug combination data analysis needs
Assistant Professor Jing Tang, a principal investigator of the Network Pharmacology group at FIMM and at the UH Faculty of Medicine has led the development of DrugComb, an open resource for harmonizing cancer drug combination studies. Dr. Tang hopes that DrugComb would become a collaborative data analysis platform that would bring forth more…
2019.03.15 | Publication
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
The study was conducted by research groups lead by Jing Tang at the Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) and the Faculty of Medicine and Caroline Heckman at FIMM. The results were recently published in PLOS Computational Biology.
